© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is powerful

Together is powerful

Search by Practice

Insights & News /  Corporate

April 3, 2019
Event: The Role of Boards of Directors in Maintaining Honesty
Our firm hosted today the Israel's Directors Union for a seminar on the prevention of bribery and corruption. Dr. Zvi Gabbay lectured on the duties of boards of directors in Israel, and Adv. Hadar Israeli presented the American perspective.
March 20, 2019
Barnea Represented Danel Ltd. in the Acquisition of Levinger Group
Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.
December 24, 2018
Calcalist Article on the Breakdown of Control in Companies
Adv. Micky Barnea was interviewed for an article in Calcalist's Executive Magazine about the superseding power of CEOs over the board of directors in public companies.
May 7, 2018
IFF to Buy Israel's Frutarom
Our firm represented International Flavors Fragrances Inc. (IFF) in its acquisition of Frutarom, the Israeli flavors and ingredients maker, for USD 7.1 billion.
November 20, 2018
Barnea represented Senetas Corporation Ltd.
Our firm represented Senetas Corporation in a USD 8 million investment in the Israeli cyber company Votiro Cybersec Global Limited
November 8, 2018
Barnea Represented Sakal Global Duty Free Ltd.
Our firm represented the owner of Sakal Global Duty Free Ltd. in the sale of the company as part of the sale of the entire Sakal Group to businessman Teddy Sagi.
November 6, 2018
The People Who Shake Management: 70% on Mellanox
Micky Barnea and Adv. Steve Wolosky are featured in a TheMarker profile about being the representatives of the American investment fund Starboard Value during its investment in Mellanox.
November 6, 2018
Israel Innovation Tour: UK Delegation
Our firm hosted today a delegation of senior executives from British companies and authorities. The delegation is part of a cooperation with the consulting company Ntegra, Bird and Bird law firm and Barnea. As part of the tour, the delegation visited our firm and met several startups for potential investment. Micky Barnea also provided a case study of the activity of foreign companies in Israel.
October 16, 2018
Hosting a Delegation of French Companies from the Aerospace Industry
Barnea hosted today a French delegation of major aerospace companies. The delegation's participants came to Israel to initiate commercial partnerships and technological cooperation with their Israeli counterparts.
August 14, 2018
What's Best for a Business: Controlling Shareholder or Executive Management?
Adv. Micky Barnea, our firm's Managing Partner, is featured in an extensive interview with TheMarker on the question of what contributes more to the proper management of a company—a dominant controlling shareholder or executive management—and how this affects the work of the board of directors.
August 7, 2018
Legal 500 Briefing: Foreign Investment in Israel
Advs. Michael Barnea and Mayer Winkler co-authored the chapter on foreign investment in Israel in the Legal 500 guide, providing information on the key factors to consider when looking to invest in Israeli companies by way of MA.
July 5, 2018
Workshop on Managing Israeli Subsidiaries of Multinational Corporations
Barnea hosted today, together with the Ministry of Economy, a workshop on the corporate and labor laws relevant to officers of Israeli subsidiaries of multinational companies.
June 11, 2018
Micky Barnea Attends Association of Corporate Counsel (ACC) Annual Event
Israel’s top legal experts and in-house counsels participated in the ACC Israel Annual Summit: "The Challenging Role of In-House Counsels in Israel.” At the event, Micky Barnea took part in the panel discussion on the relationship between corporate counsel and external legal advisors.
February 1, 2018
Barnea Advised on the $703 Million Acquisition of Theramex by CVC
Barnea Advised on the $703 Million Acquisition of Theramex by CVC Capital Partners. Theramex is Teva Pharmaceutical Industries' global women’s health portfolio.
May 9, 2018
Barnea Represented ADM Capital in Investment in Israeli Startup Rootility
Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.
May 30, 2018
How to Protect Your Trade Secrets
Barnea and Bird and Bird are hosting today a seminar on the protection of trade secrets from the Israeli and European perspectives. Adv. Marie Tsion will discuss the confidentiality and non-compete clauses in employment agreements.
March 27, 2018
Barnea Represented Cellebrite in the Sale of the Mobilogy Division to a US Fund
Our firm represented Cellebrite in the sale of the Mobilogy Division to the American ESW Capital Fund. The Mobilogy division, which operates as a separate brand, offers technological solutions for operators, retailers and aftermarket  that enhance the customer experience in-store beyond.
May 22, 2018
Landmark Israeli Court Decision Halts Deal between Two US Companies
An Israeli court has ordered to halt an investment deal in Arcturus Therapeutics, pending clarification of the lawsuit filed by Joseph Payne, the company's founder, regarding the cancellation of his dismissal as CEO. This decision was made despite the fact that the company operates in the United States with American management. Joseph Payne is represented by Advs. Micky Barnea, Zohar Lande, Noa Havdala, Omer Keydar, and Ron Shuhatovich.
May 16, 2018
Barnea & ACC Seminar: The Future of Compliance
We are hosting today, together with the Association of Corporate Counsel, a seminar on compliance and internal investigations. Dr. Zvi Gabbay will discuss new regulatory challenges, while managing directors from Duff Phelps will discuss the changing compliance environment.
May 14, 2018
Ethemba Capital Selling Control in Avgol to Indorama Ventures
Our firm is representing British private equity firm Ethemba Capital in its sale of control in Israeli company Avgol Nonwoven Industries Ltd. to Indorama Ventures Spain S.L., a chemical manufacturer whose shares are traded on the Thai stock exchange. The price of the sale is valued at NIS 1.7 billion.
Enter your email for newsletter sign up: